You turds DO realize EPS witll be over $2 for Q2 $8 annuilized. That's $8 a share as of now.....
as in this quarter, $8, now, currently, and the ramp up hasn't yet hit it's stride, as in, Europe, Japan, Canada, Astrailia, etc. Europe market as large as US, and Japan, Cananda etc, at least half, meaning a whole lot of grouwth still on the horizon.
Sure their will be competition, but even with a third of a mature market will mean revenuuses of well over 10 million a year for years to come.
No, I don't think they deserve a huged mutilple of whatever the repeatable mature market run rate, as they will have a hudge core rev runrate rate they will need to grow of of, but a 12 times 8 a share current run rate gets one to a $96 share price.
Well form one turd to another. Surprise you must be the last one to know this since it`s been talked about for months that GILD may do $ 9.00 . They did about a buck on Sovaldi sales of 2 billion. That's mean on 12 billion in sales at least $ 6.00 per share plus the normal $ 2.00 all other drugs. Don`t tell us . We are at the mercy of the big guys.